Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. by Giacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, Agnieszka Krzyzanowska, Chandra P Prasad, Anders Bjartell, Tommy Andersson

Get full text

An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium by Sebastiaan Remmers, Katharina Beyer, Tariq A. Lalmahomed, Peter Prinsen, Nicole J.E. Horevoorts, Nora Tabea Sibert, Christoph Kowalski, Francesco Barletta, Oliver Brunckhorst, Giorgio Gandaglia, Jochem R.N. van der Voort van Zyp, Emma J. Smith, Andre Deschamps, Laurence Collette, Philip Cornford, Susan Evans-Axelsson, James N’Dow, Mieke Van Hemelrijck, Monique J. Roobol, Lionne D.F. Venderbos

Get full text

AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium by Vasileios Sakalis, Yagnaseni Bhattacharya, Katharina Beyer, Charlotte Murray, Emma Jane Smith, Peter-Paul M. Willemse, Giorgio Gandaglia, Romain Boissier, Angelika Borkowetz, Saeed Dabestani, Renee C.A. Leenen, Antoni Vilaseca, Gianluca Maresca, Jeremy Teoh, Juan Gómez Rivas, Pawel Rajwa, Michael Lardas, Nikolas Grivas, Thomas Van den Broeck, Benjamin Pradere, Natasha Schouten, Zafer Tandogdu, Susan Evans-Axelsson, Steven Maclennan, Marlene Thomas, Alberto Briganti, Anders Bjartell, Phil Cornford, Hagen Kruger, James N’Dow, Monique J. Roobol, Muhammad Imran Omar

Get full text